首页> 外文期刊>Clinical rehabilitation >Effectiveness of myofascial release in treatment of chronic musculoskeletal pain: a systematic review
【24h】

Effectiveness of myofascial release in treatment of chronic musculoskeletal pain: a systematic review

机译:肌筋膜释放治疗慢性肌肉骨骼疼痛的有效性:系统评价

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate the evidence on the effectiveness of myofascial release therapy to relieve chronic musculoskeletal pain and to improve joint mobility, functioning level, and quality of life in pain sufferers. Data sources and review: Randomized controlled trials were systematically gathered from CENTRAL, Medline, Embase, CINAHL, Scopus, and PEDro databases. The methodological quality of articles was assessed according to the Cochrane Collaboration’s domain-based framework. In addition, the effect sizes of main outcomes were calculated based on reported means and variances at baseline and in follow-up. Results: Of 513 identified records, 8 were relevant. Two trials focused on lateral epicondylitis ( N = 95), two on fibromyalgia ( N = 145), three on low back pain ( N = 152), and one on heel pain ( N = 65). The risk of bias was considered low in three and high in five trials. The duration of therapy was 30–90 minutes 4 to 24 times during 2–20 weeks. The effect sizes did not reach the minimal clinically important difference for pain and disability in the studies of low back pain or fibromyalgia. In another three studies with the high risk of bias, the level of minimal clinically important difference was reached up to two-month follow-up. Conclusion: Current evidence on myofascial release therapy is not sufficient to warrant this treatment in chronic musculoskeletal pain.
机译:目的:评价肌筋膜释放治疗效果,以缓解慢性肌肉骨骼疼痛,提高疼痛患者患者的联合流动性,运作水平和生活质量。数据来源和审查:随机控制试验系统地从中央,MEDLINE,EMBASE,CINAHL,SCOPUS和PEDRO数据库中收集。根据Cochrane协作的基于领域的框架评估了物品的方法论质量。此外,主要结果的效果大小是基于基线和随访的报告的手段和差异来计算。结果:513个确定的记录,8个相关。两项试验专注于侧颌骨炎(n = 95),两个在纤维肌痛(n = 145)上,在低背部疼痛(n = 152)上,一个在脚后跟疼痛(n = 65)上。五项试验中,偏见的风险被认为是低三分之一。在2-20周内,治疗的持续时间为30-90分钟4至24次。在低腰疼痛或纤维肌痛的研究中,效果大小没有达到疼痛和残疾的最小临床重要差异。在另外三项研究中具有高风险的偏见风险,最小临床重要差异的水平达到了两个月的随访。结论:目前关于肌筋膜释放治疗的目前证据不足以在慢性肌肉骨骼疼痛中保证这种治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号